Home Newsfeeds Wedbush Initiates Coverage On PepsiCo with Outperform Rating, Announces Price Target of $185

Wedbush Initiates Coverage On PepsiCo with Outperform Rating, Announces Price Target of $185

Wedbush analyst Gerald Pascarelli initiates coverage on PepsiCo (NASDAQ:PEP) with a Outperform rating and announces Price Target of $185.

byBenzinga Newsdesk

October 11, 2022

1 minute read

Wedbush analyst Gerald Pascarelli initiates coverage on PepsiCo (NASDAQ:PEP) with a Outperform rating and announces Price Target of $185.

Truist Securities Maintains Hold on Netflix, Lowers Price Target to $210

By Benzinga Newsdesk

July 1, 6:18 AM

Truist Securities analyst Matthew Thornton maintains Netflix (NASDAQ:NFLX) with a Hold and lowers the price target from $300 to $210.

NFLX

ProPhase Labs Esophageal Cancer Early Detection Test (BE-smart) Featured in Peer-Reviewed Article in the International Journal of Molecular Science

By Benzinga Newsdesk

February 16, 9:17 AM

To date, the BE-Smart test has been tested on over 200 human samples by mProbe Inc, a precision health and medicine company utilizing clinical proteomics in the oncology space, and has shown greater

PRPH

What’s Going On With Alibaba Stock Monday?

By Anusuya Lahiri

September 25, 7:55 AM

Alibaba Group Holding Limited (NYSE: BABA) stock is trading lower on Monday in line with the broader indexes IShares China Large-Cap ETF (NYSE: FXI) and KraneShares Trust KraneShares CSI China Int

BABA

The Duckhorn Portfolio, Inc. Sees FY24 EPS $0.67-$0.69 Vs $0.68 Est.; Revenue $420M-$427M Vs $430.24M Est.

By Benzinga Newsdesk

December 6, 5:14 PM

Fiscal Year 2024 GuidanceThe Company is updating guidance to the following ranges below for Fiscal Year 2024 (excluding any impact from the pending acquisition of Sonoma-Cutrer Vineyards):(amounts in millions, except per

NAPA

Wedbush Initiates Coverage On PepsiCo with Outperform Rating, Announces Price Target of $185

Related Posts

Truist Securities Maintains Hold on Netflix, Lowers Price Target to $210

ProPhase Labs Esophageal Cancer Early Detection Test (BE-smart) Featured in Peer-Reviewed Article in the International Journal of Molecular Science

What’s Going On With Alibaba Stock Monday?

The Duckhorn Portfolio, Inc. Sees FY24 EPS $0.67-$0.69 Vs $0.68 Est.; Revenue $420M-$427M Vs $430.24M Est.